Comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as 2nd-line treatment for gastric cancer

被引：0
|
作者：
Tsuji, Kunihiro [1 ]
Miyajima, Saori [1 ]
Kito, Yosuke [1 ]
Doyama, Hisashi [1 ]
机构：
[1] Ishikawa Prefectural Cent Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.672
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-4
引用
收藏
页码：S330 / S330
页数：1
相关论文
共 50 条
  • [1] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Ishikawa, Masashi
    Iwasa, Satoru
    Nagashima, Kengo
    Aoki, Masahiko
    Imazeki, Hiroshi
    Hirano, Hidekazu
    Shoji, Hirokazu
    Honma, Yoshitaka
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Saruta, Masayuki
    Boku, Narikazu
    [J]. INVESTIGATIONAL NEW DRUGS, 2020, 38 (02) : 533 - 540
  • [2] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Masashi Ishikawa
    Satoru Iwasa
    Kengo Nagashima
    Masahiko Aoki
    Hiroshi Imazeki
    Hidekazu Hirano
    Hirokazu Shoji
    Yoshitaka Honma
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Masayuki Saruta
    Narikazu Boku
    [J]. Investigational New Drugs, 2020, 38 : 533 - 540
  • [3] Efficacy and safety of nab-paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment for patients with advanced gastric cancer: A single institutional experience
    Okunaka, Mashiro
    Kotani, Daisuke
    Demachi, Ken
    Kawazoe, Akihito
    Yoshino, Takayuki
    Shitara, Kohei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [4] Nab-paclitaxel plus ramucirumab combination therapy as second-line with advanced gastric cancer:Retrospective study
    Kashiwada, Tomomi
    Nishioka, Atsujiro
    Komiya, Kazutoshi
    Aragane, Naoko
    Kimura, Shinya
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 140 - 140
  • [5] Examination of utility in patients of unresectable or recurrent gastric cancer treated with paclitaxel or nab-paclitaxel or paclitaxel plus ramucirumab in our hospital
    Kii, T.
    Gotoh, M.
    Terazawa, T.
    Yamaguchi, T.
    Asaishi, K.
    Aoki, M.
    Ikegami, T.
    Higuchi, K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 61 - 61
  • [6] Ramucirumab plus paclitaxel for gastric cancer in China
    Yoon, Harry H.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 975 - 976
  • [7] A phase II study of nab-paclitaxel plus ramucirumab for the second-line treatment of patients with metastatic gastroesophageal cancer
    Bendell, Johanna C.
    Percent, Ivor John
    Weaver, Robert Waide
    Chua, Cynthia Coo
    Xiong, Henry Q.
    Cohn, Allen Lee
    Zakari, Ahmed
    Singh, Jaswinder
    Kozloff, Mark
    Lietman, Caressa
    Lane, Cassie Michelle
    Jones, Suzanne Fields
    Finney, Lindsey H.
    Carmody, Sean
    Womack, Mark Sanders
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [8] A randomized phase II trial of paclitaxel plus ramucirumab versus nab-paclitaxel plus ramucirumab for gastric cancer with peritoneal dissemination refractory to first-line therapy (WJOG10617G/P-SELECT)
    Hirata, Kenro
    Hamamoto, Yasuo
    Shoji, Hirokazu
    Hara, Hiroki
    Kondoh, Chihiro
    Yasui, Hisateru
    Kajiwara, Takeshi
    Baba, Eishi
    Ando, Takayuki
    Sugimoto, Naotoshi
    Okano, Naohiro
    Kawakami, Hisato
    Katsuya, Hiroo
    Nagase, Michitaka
    Moriwaki, Toshikazu
    Yoshimura, Kenichi
    Ando, Masahiko
    Yamazaki, Kentaro
    Hironaka, Shuichi
    Muro, Kei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [9] Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
    Mashiro Okunaka
    Daisuke Kotani
    Ken Demachi
    Akihito Kawazoe
    Takayuki Yoshino
    Toshikatsu Kawasaki
    Kohei Shitara
    [J]. BMC Cancer, 20
  • [10] Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
    Okunaka, Mashiro
    Kotani, Daisuke
    Demachi, Ken
    Kawazoe, Akihito
    Yoshino, Takayuki
    Kawasaki, Toshikatsu
    Shitara, Kohei
    [J]. BMC CANCER, 2020, 20 (01)
12345